Born in November 2019, Benjamin Gobrecht’s arrival was a “perfect miracle” for his parents, Jennifer and Drew, and a medical milestone for researchers at Penn Medicine. He was the first baby born as part of Penn’s uterus transplant clinical trial.
Penn Medicine birth marks a milestone in uterus transplant clinical trial
The birth is Penn’s first as part of its uterus transplant clinical trial, and second in the United States following a deceased donor transplant.
The new study reveals that indicators of the condition included mentions of hostility and loneliness, words like “tears” and “feelings,” and use of more first-person pronouns like “I” and “me.”
Linguistic red flags from Facebook posts can predict future depression diagnoses
The language people use in these social media posts can make these predictions as accurately as the tools clinicians use in medical settings to screen for the disease.
In the latest round of research on the effects of greening vacant lots, criminologist John MacDonald and emergency medicine physician Eugenia South found that people living within a quarter mile of greened lots had a 41.5 percent decrease in feelings of depression and a nearly 63 percent decrease in self-reported “poor mental health” compared to those who lived near the lots that received no intervention.
Greening vacant lots reduces depression in city dwellers
People living within a quarter mile of greened lots had a 41.5 percent decrease in feelings of depression and a nearly 63 percent decrease in self-reported “poor mental health,” compared to those who lived near the lots that received no intervention.
Amy Kraft and her family. (Photo courtesy of Amy Kraft)
Addressing unseen scars of a traumatic brain injury head on
Research at Penn Med explores the lasting effect of traumatic brain injuries on the nervous system to expand how we understand physical injury to the brain and behavior.
FDA Approves Gene Therapy for Inherited Blindness Developed by Penn and CHOP
In a historic move, the U.S. Food and Drug Administration (FDA) today approved a gene therapy initially developed by researchers at the University of Pennsylvania and Children’s Hospital of Philadelphia (CHOP) for the treatment of a rare, inherited form of retinal blindness.
New $21 Million Gift Puts Basser Center for BRCA at the Forefront of Advancements for Patients At Risk of Inherited Cancers
A new $21 million gift to the Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania from alumni Mindy and Jon Gray will cement and propel Penn’s preeminence as a
Penn Study: Bacteria in the Cervix May be Key to Understanding Premature Birth
Depending on the specific type, bacteria in a woman’s vagina and cervix may increase the risk of premature birth or protect against it, according to new research from the Perelman School of Medicine at the University of Pennsylvania.
A banner year for breakthroughs: Penn Medicine’s most talked-about news in 2016
Some of Penn Medicine’s biggest accomplishments included employing virtual reality devices to treat phantom limb pain, performing Penn’s third bilateral hand transplant, and using CRISPR to treat hemophilia in mice.
Penn Medicine: 100 Million Prescription Opioids Go Unused Each Year Following Wisdom Teeth Removal
ore than half of opioids prescribed to patients following surgical tooth extraction – such as the removal of impacted wisdom teeth – were left unused by patients in a new study from researchers at the University of Pennsylvania’s Perelman School of Medicine and School of Dental Medicine.
